Cargando…
Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
PDGF-CC is a member of the platelet-derived growth factor (PDGF) family that stimulates PDGFRα phosphorylation and thereby activates intracellular signalling events essential for development but also in cancer, fibrosis and neuropathologies involving blood-brain barrier (BBB) disruption. In order to...
Autores principales: | Li, Hong, Zeitelhofer, Manuel, Nilsson, Ingrid, Liu, Xicong, Allan, Laura, Gloria, Benjamin, Perani, Angelo, Murone, Carmel, Catimel, Bruno, Neville, A. Munro, Scott, Fiona E., Scott, Andrew M., Eriksson, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063412/ https://www.ncbi.nlm.nih.gov/pubmed/30052660 http://dx.doi.org/10.1371/journal.pone.0201089 |
Ejemplares similares
-
Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CC(hum) mice
por: Zeitelhofer, Manuel, et al.
Publicado: (2018) -
Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
por: Zeitelhofer, Manuel, et al.
Publicado: (2020) -
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke
por: Su, Enming Joseph, et al.
Publicado: (2017) -
Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat
por: Seki, Takahiro, et al.
Publicado: (2016) -
PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy
por: Xu, Jie, et al.
Publicado: (2018)